Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹1,653 Cr₹892 Cr₹1,005 Cr₹484 Cr₹766 Cr

What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA is ₹1,653 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹1,653 Cr
Mar2025₹892 Cr
Mar2024₹1,005 Cr
Mar2023₹484 Cr
Mar2022₹766 Cr

How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹1,653 Cr
85.21
Mar2025 ₹892 Cr
-11.17
Mar2024 ₹1,005 Cr
107.60
Mar2023 ₹484 Cr
-36.86
Mar2022 ₹766 Cr -

Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,683.8 Cr 5.8% 4.9% -13.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,005.0 Cr 2.7% 7.5% 12.8% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4.2% 3.9% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹163,246.0 Cr 4.3% 11.2% 42.5% Stock Analytics
CIPLA ₹118,854.0 Cr 0.4% 5.3% -3% Stock Analytics
DR REDDYS LABORATORIES ₹114,246.0 Cr 0.9% 8% 5.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

5.8%

4.9%

-13.3%

SENSEX

2%

5.3%

-6.5%


You may also like the below Video Courses